Biomarin Pharmaceutical Inc

Filings by Biomarin Pharmaceutical Inc span 2 companies, the busiest being La Jolla Pharmaceutical Co and Catalyst Pharmaceuticals, Inc. We count 5 filings; the first trade dates from 27 March 2009 and the latest from 8 December 2012.

The open-market side counts 1 purchase for €2.9M alongside 3 sales for €862k. The net balance comes to €2.0M on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2012, the count stands at 1 purchase and no sales.

On 12 December 2012 came the latest disclosure, an open-market purchase for €2.9M in Catalyst Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.